International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia (2023)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1038/s41569-023-00892-0
- Subjects: HIPERCOLESTEROLEMIA; ARTERIOSCLEROSE CORONÁRIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Nature reviews cardiology
- ISSN: 1759-5002
- Volume/Número/Paginação/Ano: v. 20, n. 12, p. 845-869, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WATTS, Gerald F et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nature reviews cardiology, v. 20, n. 12, p. 845-869, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57897. Acesso em: 27 jan. 2026. -
APA
Watts, G. F., Gidding, S. S., Hegele, R. A., Raal, F. J., Sturm, A. C., Jones, L. K., et al. (2023). International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nature reviews cardiology, 20( 12), 845-869. doi:10.1038/s41569-023-00892-0 -
NLM
Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, Sarkies MN, Al-Rasadi K, Blom DJ, Santos Filho RD dos. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia [Internet]. Nature reviews cardiology. 2023 ; 20( 12): 845-869.[citado 2026 jan. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57897 -
Vancouver
Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, Sarkies MN, Al-Rasadi K, Blom DJ, Santos Filho RD dos. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia [Internet]. Nature reviews cardiology. 2023 ; 20( 12): 845-869.[citado 2026 jan. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57897 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.1038/s41569-023-00892-0 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
